Followers
@netsas.bsky.socialNeuroendocrine Tumor Research Foundation @netrf.org Driving research to discover cures & more effective treatments for neuroendocrine cancers.
Rezolute Medical Affairs @rzltmedaffairs.bsky.social As representatives of a rare disease biotech company, we’re committed to connecting with healthcare professionals and advocates to foster transparent, meaningful conversations in the rare disease space.
Ancora.ai Cancer Clinical Trial Finder @ancoraai.bsky.social Ancora.ai is an AI-enabled digital platform that enables cancer patients & their care teams to find trials. We believe technology can help improve access and make clinical trial recruitment more efficient. Check out the tool at www.ancora.ai
Therapeutic Advances in Endocrinology and Metabolism @theendo.bsky.social Your go-to source for the latest research and fresh perspectives on endocrine and metabolic conditions. #endocrinologyjournal IF=4.6 https://journals.sagepub.com/home/tae
Thor Halfdanarson @oncothor.bsky.social 🇮🇸 🇺🇸 Medical Oncologist/Educator, NET/GI/CUP enthusiast. Husband/dad x4 (bad dad jokes). Cyclist. Avant gardener. Professor of Oncology, Mayo Clinic. Tweets mine, not endorsement/advice. https://tinyurl.com/22w4kxjj #NETsSky #MedSky #OncSky
International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social Raising awareness of neuroendocrine cancers around the world. November 10 is NET Cancer Day. INCA is the global voice of NET patients. www.incalliance.org